These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 20643463)
1. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. Ohno Y; Nakashima J; Ohori M; Hatano T; Tachibana M J Urol; 2010 Sep; 184(3):873-8. PubMed ID: 20643463 [TBL] [Abstract][Full Text] [Related]
2. Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma. Ohno Y; Nakashima J; Ohori M; Gondo T; Hatano T; Tachibana M J Urol; 2012 Feb; 187(2):411-7. PubMed ID: 22177153 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
7. Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival. Jeong IG; Yoo CH; Song K; Park J; Cho YM; Song C; Hong JH; Ahn H; Kim CS J Urol; 2009 Aug; 182(2):445-50. PubMed ID: 19524959 [TBL] [Abstract][Full Text] [Related]
8. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy. Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843 [TBL] [Abstract][Full Text] [Related]
9. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167 [TBL] [Abstract][Full Text] [Related]
10. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality. Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of body mass index in Korean patients with renal cell carcinoma. Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis. Chang X; Zhang F; Liu T; Wang W; Guo H Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169 [TBL] [Abstract][Full Text] [Related]
14. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma. Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384 [TBL] [Abstract][Full Text] [Related]
15. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. Donskov F; von der Maase H J Clin Oncol; 2006 May; 24(13):1997-2005. PubMed ID: 16648500 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158 [TBL] [Abstract][Full Text] [Related]
17. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma. Hafez KS; Novick AC; Campbell SC J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105 [TBL] [Abstract][Full Text] [Related]
19. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783 [TBL] [Abstract][Full Text] [Related]
20. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Ishimura T; Sakai I; Hara I; Eto H; Miyake H Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]